Introduction {#sec1-1}
============

Cancer/Testis (CT) genes are a diverse group of testis specific genes, atypically expressed in about 40% of different types of cancers ([@ref1]). Blood-testis barrier creates an immune privileged site for the germ cell antigens. Restricted expression profile of CTAs in normal testis, makes them not accessible to cytotoxic lymphocytes, so it does not express the major histocompatibility complex molecule ([@ref1]). A subfamily of the CT genes encode immunogenic antigens and stimulate immune responses in cancer patients ([@ref2]).

Testis has many similarities with cancerous tissues like cell division, immigration, and immortal- lization. Various CT genes have similar action with different types of cancers and oocyte maturation; example been WWP2 N-terminal-like, a testis-specific signaling protein, induces meiotic resump- tion and oocyte activation events, and is also expressed in actively dividing cancerous cell lines ([@ref3]). The CT genes, OIP5, TAF7L ([@ref4]), and AURKC ([@ref5]) have been demonstrated as promising and potent candidates for therapeutic cancer vaccines and biomarkers for breast cancer.

However, the immunohistochemical analysis of MAGE-1 in lung neoplasms has suggested that mRNA expression of a CT antigen in a tumor doesn't mean it could be used as an immunotherapeutic target because homogenous protein expression in the target tissues is essential ([@ref6]) ([Figure 1](#F1){ref-type="fig"}). CT genes are not only expressed in solid tumors but have also been implicated in hematopoietic neoplasms like acute lymphoblastic leukemia ([@ref7]).

![CTAs expression in normal and tumor tissues; A: Immunohistochemical staining displays the expression of MAGE4 by testicular germ cells B: Squamous cell carcinoma. An area of MA454 reactivity next to an immunonegative tumor area (heterogeneous expression of the CTA) C: Expression of NY-ESO-1 in urinary bladder carcinoma. The brown staining shows antibody binding. This Figure was reproduced from references ([@ref2], [@ref6])](IJBMS-20-967-g001){#F1}

The nomenclature of CT genes depends on any gene that demonstrates an mRNA expression profile limited to the testis and neoplastic cells. Several characteristic features and definitions of CTAs have emerged in different researches varying from genes exhibited solely in adult testis germ cells and tumors ([@ref8]), to dominant testicular expression ([@ref9]) and also possibly expressed in placenta and ovary, regulated by epigenetic mechanisms ([@ref10]) and mapping to the X chromosome ([@ref11]) ([Table 1](#T1){ref-type="table"}). The CT database has listed more than 250 RefSeq nucleotide identifiers belonging to about 150 gene families ([www.cta.lncc.br](http://www.cta.lncc.br)). The human X chromosome houses about 10% of CT genes ([@ref12]).

###### 

Characteristics of CT-X genes

  CTA gene family   Number of genes in the family   CT family   Chromosome location   Expression during germline maturation   Functions in spermatogenesis
  ----------------- ------------------------------- ----------- --------------------- --------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------
  CAGE              1                               CT26        Xp22.13               spermatids, spermatozoa                 possible helicase
  CSAGE             2                               CT24        Xq28                  ND                                      unknown
  CTp11/SPANX       4                               CT11        Xq27.1                spermatids                              unknown
  E2F-like/HCA661   1                               CT30        Xq26.2                ND                                      transcription factor
  FATE1             1                               CT43        Xq28                  ND                                      unknown
  FTHL17            1                               CT38        Xp21                  spermatogonia                           possible ferritin heavy polypeptide-like protein
  GAGE1             8                               CT4         Xp11.4--p11.2         ND                                      unknown
  HOM-TES-85        1                               CT28        Xq23                  ND                                      possible transcriptional regulatory protein
  IL13RA1           1                               CT19        Xq24                  ND                                      receptor for interleukin-13
  MAGEA             12                              CT1         Xq28                  spermatogonia                           translational co-repressor and male infertility
  MAGEB             4                               CT3         Xp21--p22             migration PGCs                          unknown
  MAGEC1            2                               CT7         Xq26, Xq27.2          ND                                      unknown
  MAGEC2            1                               CT10        Xq27                  ND                                      unknown
  NA88              1                               CT18        Xp22.12               ND                                      unknown
  NXF2              1                               CT39        Xq22.1                spermatogonia                           mrna export to the cytoplasm
  NY-ESO-1          3                               CT6         Xq28                  spermatogonia                           unknown
  NY-SAR-35         1                               CT37        Xq28                  ND                                      enhances spermatogonial cell migration and proliferation
  PAGE5             2                               CT16        Xp11.22               ND                                      unknown
  SAGE1             1                               CT14        Xq26                  ND                                      sage1 supports the origin of spermatocytic seminoma from spermatogonia and provides new evidence for heterogeneity spermatocytic seminoma
  SSX               5                               CT5         Xp11.23--p11.22       ND                                      translational co-repressor
  XAGE1/GAGED       8                               CT12        Xp11.22--p11.21       ND                                      unknown

CAGE, cancer antigen 1; CSAGE, chondrosarcoma-associated gene 1; FATE1, fetal and adult testis expressed 1; FTHL17, ferritin, heavy polypeptide-like 17; GAGE1, G antigen 1; IL13RA1, interleukin-13 receptor- α1; MAGE, melanoma antigen; ND, not determined; NXF2, nuclear RNA export factor 2; NY-SAR-35, New York sarcoma 35; PAGE5, P antigen family, member 5; PGCs, primordial germ cells; SAGE1, sarcoma antigen 1; SPANX, sperm associated with the nucleus, X chromosome; SSX, synovial sarcoma; TAF7L, TAF7-like RNA polymerase II, XAGE1, X antigen family, member

Classification of cancer/testis genes {#sec2-1}
-------------------------------------

A classification system of CTAs suggests differential expression profiles of CTAs as (*i*) testis restricted CTAs, (*ii*) testis-brain restricted CTAs that express in the testis and central nervous system, or (*iii*) testis selective, expressed in the testis and at lower levels in 1 to 2 additional tissues, when compared to the testes ([@ref13]). Out of the 153 CT genes, 39 had transcripts presented solely in the adult testis (placenta is also classified as testis-restricted) while 14 CT genes had additional expression in the brain, though classified as te testis-brain restricted and 85 genes had their main expression in testis and classified as testis-selective ([@ref13]). Strangely, X chromo-some is the location for almost half of the explained CT genes and these are known as CT-X genes. CT-X genes characteristically exhibit a testis-restricted expression profile and they possess more antigenic properties than non-CT-X CTAs that are located all over the autosomes. Many CT-X genes are sub-family members of larger families like the MAGEs, which are made up of genes like MAGEA1-- 12, MAGEB1--18, and MAGEC1-7 ([@ref14]). MAGE proteins from all sub-families at amino level exhibit 46% conservation and most of the subfamilies consist of a MAGE homology domain. Group 1 subfamily consists of MAGEs in the A, B, and C classes consisting of more than 45 genes and is restricted to the testis and to tumors. Classes D to I and NECDIN are within the Group II and they are expressed in a broad range of tissues ([@ref14]). There are other notable families of CT-X genes like GAGE, PAGE, XAGE, SPANX, SSX, NY-ESO-1, PIWIL2, and CT47A ([@ref15]).

It seems that expression of CTAs like MAGE, BAGE, and GAGE gene families in cancer cells is not randomly distributed among different individuals and family members of these genes tend to be clustered in a different subset of tumors, signifying a common mechanism for transcriptional activation (e.g. methylation) ([@ref16]). Several researchers have carried out numerous studies to investigate the frequency of expression of CTAs in tumors though most of it has been truncated by sample size. However, with large and wide-ranging data sets like that from The Cancer Genome Atlas (TCGA), an extensive analysis of CT genes expression level, state of mutation, and copy number throughout many diverse tumor types is accomplishable. The number of occurrence of reactivation of specific CTAs and the degree of activation of the whole group of CTAs can be investigated via this distinct type of analysis. In addition, any prognostic implication of CTA expression can be investigated and determined via the analysis of the reactivation patterns ([@ref17]).

Roles of cancer/testis genes in gamete formation {#sec2-2}
------------------------------------------------

The roles of CT genes in gamete formation remain comparatively unclear; however, the knowledge of gene expression and knockout studies has thrown more light on the multi-functions of CT genes. CT genes are responsible for some processes during the initial stages of spermatogenesis and their expression (CTAs, such as *MAGEA1* and *NY-ESO-1)* is evident in the early stages of spermatogenesis ([@ref6]). The association of MAGE-A1 and NY-ESO-1 with highly proliferating germ cells and a more general function for GAGE proteins in germ cells is suggested after studying the expression of these CTAs in fetal gonads by immunohistochemistry ([@ref18]). Several research studies have reported that a subset of CTAs plays essential roles in male fertility, as mice deficient of single CTAs commonly demonstrate decreased fertility ([Table 2](#T2){ref-type="table"}). CTAs also could provide important roles to a various set of processes in their local setting, suggesting that they can be efficient in providing various tumorigenic features. Normal and healthy development of the majority of knockout animals for CT genes suggests that they are not involved in processes of somatic tissues ([@ref19], [@ref20]). The primary functions of more than 140 identified members of the CT antigens still remains unknown ([@ref21], [@ref22]). However the roles of CT genes have been implicated during the process of spermatogenesis and some specific CT genes have been identified via their relationship with spermatogonia, sperma- tocytes, spermatids, and spermatozoa.

###### 

Cancer/Testis genes roles in reproduction

                               CT Family   CT genes        Ch-Location               Status                                                                                          Male phenotype                                                                      Female phenotype       [References]{.ul}
  ---------------------------- ----------- --------------- ------------------------- ----------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------- ---------------------- ----------------------
  RNA Regulation               CT80.2      PIWIL2          8p21.3                    testis-selective                                                                                viable, infertile; microrchidia, meiotic prophase arrest                            infertile              ([@ref25], [@ref26])
  CT41.1                       TDRD1       10q25.3         testis-selective          viable, infertile; microrchidia, meiotic prophase arrest                                        infertile                                                                           ([@ref27], [@ref28])   
  CT41.2                       TDRD6       6p12.3          testis-selective          viable, infertile; microrchidia, meiotic prophase arrest                                        none                                                                                ([@ref20])             
  CT128                        MAEL        1q24.1          testis-selective          viable, infertile; microrchidia, meiotic prophase arrest                                        NA                                                                                  ([@ref29])             
  Fertilization/Implantation   CT93        CALR3           19p13.11                  testis-selective                                                                                viable, infertile; sperm unable to penetrate zona pellucida                         none                   ([@ref30])
  CT92                         PLAC1       Xq26            testis-selective          viable, fertile; placentomegaly, intrauterine growth retardation                                same as male                                                                        ([@ref31])             
  CT99                         AKAP4       Xp11.2          testis-restricted         viable, infertile; fibrous sheath defect                                                        none                                                                                ([@ref32])             
  CT91                         ROPN1       3q21.1          testis-selective          viable, reduced fertility; defects in the principal piece                                       NA                                                                                  ([@ref33], [@ref34])   
  CT15                         ADAM2       8p11.2          testis-selective          viable, reduced fertility; defects in migration, adhesion to zona pellucida, sperm-egg fusion   none                                                                                ([@ref35])             
  CT34                         DKKL1       19q13.33        testis-restricted         viable, impaired fertility; defects in zona pellucida penetration                               none                                                                                ([@ref36])             
  Homologous Recombination     CT8         SYCP1           1p13-p12                  testis-selective                                                                                viable, infertile; microrchidia due to defects in homologous recombination          infertile              ([@ref37])
  CT42                         TEX15       8p12            testis-selective          viable, infertile; microrchidia due to chromosome synapse failure                               none                                                                                ([@ref38])             
  CT76                         SYCE1       10q26.3         testis-selective          viable, infertile; microrchidia due to chromosome synapse failure                               infertile                                                                           ([@ref39])             
  CT35                         SPO11       20q13.2-q13.3   testis-selective          viable, infertile; microrchidia due to chromosome synapse failure                               infertile                                                                           ([@ref40])             
  CT46                         HORMAD1     1q21.2          testis/brain-restricted   viable, infertile; microrchidia due to meiotic arrest at pachytene stage                        infertile                                                                           ([@ref41])             
  Transcription                CT33        MORC1           3q13                      testis-selective                                                                                viable, infertile; microrchidia due to meiotic arrest at zygotene/leptotene stage   none                   
  CT27                         CTCFL       20q13.31        testis-selective          viable, fertile; microrchidia, multinucleated sperm cells, increased sperm death                none                                                                                ([@ref42])             
  CT9                          BRDT        1p22.1          testis-selective          viable, fertile; oligoasthenoteratozoospermia                                                   none                                                                                ([@ref43])             
  CT41.3                       TDRD4       13q12.12        not mentioned             viable, infertile; sperm arrest at round spermatid stage                                        none                                                                                ([@ref44])             
  Other                        CT 121      ARX             Xp21                      not mentioned                                                                                   nonviable; small olfactory bulb, small testes                                       NA                     ([@ref45])
  CT56                         THEG        19pter-p13      testis-selective          viable, fertile; deletion of c-terminal domain leading to small testes                          none                                                                                                       
  CT 120.2                     TMEFF2      2q32.3          testis-selective          viable, growth retardation; die after weaning                                                   same as male                                                                        ([@ref46])             
  CT39                         NXF2        Xq22.1          testis-selective          viable, subfertile; meiotic arrest                                                                                                                                                  ([@ref47])             
  CT32                         LDHC        11p15.5-p15.3   testis-selective          Viable, Infertile; Low ATP, Diminished hyperactive motility                                     none                                                                                ([@ref48])             
  CT134                        ODF2        9q34.11         not mentioned             Not viable; Preimplantation defect                                                              not viable                                                                          ([@ref49])             
  CT40                         TAF7L       Xq22.1          testis-selective          Viable, Fertile but produce small litters; Folded/Angulated sperm tails                         none                                                                                ([@ref50])             

NA: Not Available

Primordial germ cells (PGCs) are the common origins of the germline ([Figure 2](#F2){ref-type="fig"}). PGCs migrate via the dorsal mesentery of the embryo and finally enter the region of developing fetal gonad in the genital ridge around the 10^th^ thoracic level. Within the genital ridge, if the cells are carrying a Y chromo-some, the PGCs become enclosed by the Sertoli cells and ultimately differentiate into spermatogonia type A, which proliferate and differentiate mitotically and get arrested at G1 phase until birth. However, proliferation is resumed at puberty, which in-turn initiates the process of spermatogenesis. There are two types of spermatogonia A germline, namely spermatogonia A pale and dark. Spermatogonia A dark serve as the pluripotent stem cells that can renew themselves to maintain the pool of stem cells while spermatogonia A pale can undergo differentiation and proliferation to produce more spermatozoa via two meiotic divisions. Firstly, meiosis I involving the reduction of the tetraploid primary spermatocytes to diploid secondary spermatocytes and secondly, equatorial meiotic II division to form haploid spermatids which through the process of spermiation form mature sperma-tozoa ([Figure 2](#F2){ref-type="fig"}).

![Summary of CT antigens implicated in the process of spermatogenesis](IJBMS-20-967-g002){#F2}

Most CT-X antigens like MAGE and NY-ESO-1 are implicated in the process of spermatogenesis, while CT-X antigens like SCPI, associated with meiosis, have been expressed in spermatocytes.

Furthermore, CT-X antigens like OY-TES-1/ACRBP (acrosin-binding protein), are expressed by spermatids ([@ref23], [@ref24]).

Synaptonemal complex protein 1 (SCP-1) {#sec2-3}
--------------------------------------

SCP-1, also called SYCP1, HOM-TES-14, and CT8 is selectively expressed during meiotic division I (reduction division) of spermatocytes prophase specifically from zygotene to diplotene in the human testis because it's responsible for the formation of the synaptonemal complexes ([@ref24]). SCP-1 is involved in pairing and recombination of homologous chromosomes during meiotic division I ([@ref24]). Most CT antigens are located on chromosome X, but the SCP-1 is localized on chromosome 1 ([@ref15]). The restricted expression of this CTA in pre-meiotic spermatocytes for chromosomal pairing demonstrates its importance in meiosis ([Table 2](#T2){ref-type="table"}).

ACRBP {#sec2-4}
-----

ACRBP, also known as OY-TES-1, SP32, and CT23, is an acrosin binding protein located on chromosome 12 ([@ref51]). OY-TES-1 is the human homolog of pro-acrosin binding protein sp32 precursor first described in pig and mouse testes ([@ref51]). It is only and highly expressed in the testis and localized at the acrosomal region of mature spermatozoa but not on any somatic cells. Interestingly, in a recent study it was found that while in human there is only one mRNA of the gene, in mice, the alternative splicing of the pre-mRNA of this gene is responsible for regulating the biogenesis of sperm acrosome ([@ref52]).

Piwi2 {#sec2-5}
-----

P-element induced wimpy testis (Piwi) is a class of genes involved in processes like maintaining differentiation and self-renewal in stem cells and also RNA silencing ([@ref53], [@ref54]), which was first identified in Drosophila ([@ref55]). Miwi, a murine homolog of the Piwi, is specifically expressed in spermatocytes and spermatids and encodes a cytoplasmic protein essential for spermatogenesis ([@ref56]). In addition, a stem-cell protein Piwil2 (Piwi-like 2) ([Table 2](#T2){ref-type="table"}) has been reported to be precisely expressed in the testes of humans and mice, restricted to spermatogonia and early spermatocytes ([@ref57]). It has critical roles in early prophase of meiosis and germline stem cell self-renewal in testis ([@ref25], [@ref58]). It also binds to piRNAs and mRNAs and in this way is implicated in translational regulation of many genes during early spermatogenesis ([@ref59], [@ref60]). Epigenetic studies in infertile men have shown that this disorder is associated with promoter hypermethylation associa-ted silencing of PIWIL2 and another CTA named TDRD1 ([@ref61]).

Role of cancer/testis genes in sperm metabolism {#sec2-6}
-----------------------------------------------

Several CT genes are involved in the regulation of energy production in sperm. COX6B2, a sperm- specific factor of complex IV of the electron transport chain, is a promoter of efficient oxidative phosphoryla-tion by stimulating complex IV dimerization ([@ref62]). The CT gene, SPATA19, was isolated and identified as a mitochondrial adhesion protein that efficiently stimulates the packing of mitochondria into the neck region of the sperm ([@ref63]). Conclusively the two above-mentioned CT genes could be critical in sperm to satisfy the increased energy needs for motility. Furthermore, the inter-conversion between lactate and pyruvate is catalyzed by the first testis-specific isozyme discovered, lactate dehydrogenase C (LDHC) ([@ref63]). While LDHA and LDHB are also found in the sperm, more than 80% of the LDH activity in the spermatozoa is related to LDHC ([@ref63]). The ldhc null mice are infertile with impaired motility of the sperm and inability to fertilize oocytes ([@ref63]). Odet *et al*. found inability of the sperm to consume glucose, rapid decreases in the progressive motility and ATP levels in the sperm of these knockout mice and also disruption of homeostasis ([@ref48], [@ref64]).

RNA regulation {#sec2-7}
--------------

Several research studies have investigated the role of CTAs in sustaining and regulating mRNA expression in sperm cells. The mouse orthologues of the CTAs PIWIL2 and TDRD1, in association with piwi-interacting RNAs (piRNAs), may be responsible for silencing transposons during spermatogenesis. Deletion of either PIWIL2 or TDRD 1 results in prophase stage arrest of spermatogenesis thus increasing transposon LINE-1 expression ([@ref27], [@ref65]). Interestingly, the chromatoid body, which houses mRNAs and RNA-binding proteins, promotes regulation of gene expression during spermiogenesis during inactive transcription ([@ref66]) and houses numerous CT genes. Furthermore, several CT genes like TDRD6, TDRD1, MAEL, and MILI have also been identified within the chromatoid body and research studies have reported that mice lacking CT genes like TDRD6 and MAEL have arrested spermatogenesis at the round spermatid stage, thereby leading to infertility in male mice ([@ref19], [@ref20], [@ref67]). It should be noted that mice lacking MAEL, MILI, TDRD6, and TDRD1 have been reported viable and healthy, suggesting that theses CT genes are non-essential for somatic cells ([@ref19], [@ref20]).

Ct genes functions in relation to sperm motility {#sec2-8}
------------------------------------------------

Sperm motility is mediated by the flagellum via its undulatory movement which moves the sperm forward. The sperm flagellum is made of the axoneme, the outer dense fibers, and the fibrous sheath. The axoneme is in turn made up of dynein-and-tubulin radial-spoke structure that specifically mediates its movement. The axoneme has an outer protective fibrous sheath covering it that regulates its structure. The structure of the flagella is made up of at least 13 known proteins and 50% of the flagella structure is made up of a CT gene called AKAP4. It should be noted that the CTAs; AKAP3, CABYR, SPA17, ROPN1, and TSGA10 also constitute the fibrous sheath ([@ref68]-[@ref70]). Double knockout mice for *ROPN* and *ROPN1L* have infertility due to defects in flagellum structure and immotile sperm ([@ref33]). The molecular mechanisms that coordinate and regulate the movement of the flagellum are still not lucid; however CT genes like AKAP4, rhophilin-1, and ropporin have been demonstrated to be present in flagella structures thereby suggesting active signaling cascades in sperm.

To study genes behavior during mouse spermatogenesis, the *in vitro* derived germ cells could be a credible model ([@ref71]). In this way, the expression pattern of TSGA10 as a known Cancer/Testis gene ([@ref72], [@ref73]), is similar during *in vitro* and *in vivo* germ cell generation ([@ref71]). TSGA10 has a critical function during spermatogenesis ([@ref74]).

Conclusion {#sec1-2}
==========

Most of the physiological functions for some of the CT antigens during spermatogenesis still remain unknown, however, some of these CT antigens have been investigated and identified as proteins closely related to: (a) Spermatogonial stem cells via mitosis like Piwil2, (b) Transcription regulation like SS18-SSX proteins, (c) SCP-1 functions in the crossing over process in spermatocytes to during prophase 1 meiotic division I, (d) Germ cell apoptosis like MAGE proteins and Piwil2, and the function of OY-TES-1 and SP-17 in spermiogenesis and sperm motility, respectively. Conclusively [Figure 2](#F2){ref-type="fig"} gives a summarized illustration about CT antigens involved in the various phases of cellular events related to spermatogenesis.
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